Last update 13 May 2025

Mequitazine/Atropa belladonna extract/Glycyrrhizinate dipotassium/Pseudoephedrine Hydrochloride/Caffeine

Overview

Basic Info

Drug Type
Small molecule drug, Herbal medicine
Synonyms-
Target
11β-HSD1 x A1R x A2aR x Adenosine receptor x H1 receptor x PDEs x α-adrenergic receptor
Action
inhibitors, agonists, antagonists
Mechanism
11β-HSD1 inhibitors(Corticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors), A1R agonists(Adenosine A1 receptor agonists), A2aR antagonists(Adenosine A2a receptor antagonists)
Therapeutic Areas
Immune System DiseasesInfectious DiseasesOtorhinolaryngologic Diseases+ [1]
Active Indication
Common ColdRhinitis, Allergic
Inactive Indication-
Originator Organization
SK Chemicals Co. Ltd.SK Chemicals Co. Ltd.
Active Organization
SK Chemicals Co. Ltd.SK Chemicals Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
South Korea (11 Apr 2025),
Common ColdRhinitis, Allergic
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC10H16ClNO
InChIKeyBALXUFOVQVENIU-KXNXZCPBSA-N
CAS Registry345-78-8
View All Structures (5)

Related

100 Clinical Results associated with Mequitazine/Atropa belladonna extract/Glycyrrhizinate dipotassium/Pseudoephedrine Hydrochloride/Caffeine
Login to view more data
100 Translational Medicine associated with Mequitazine/Atropa belladonna extract/Glycyrrhizinate dipotassium/Pseudoephedrine Hydrochloride/Caffeine
Login to view more data
100 Patents (Medical) associated with Mequitazine/Atropa belladonna extract/Glycyrrhizinate dipotassium/Pseudoephedrine Hydrochloride/Caffeine
Login to view more data
100 Deals associated with Mequitazine/Atropa belladonna extract/Glycyrrhizinate dipotassium/Pseudoephedrine Hydrochloride/Caffeine
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Common Cold
South Korea
SK Chemicals Co. Ltd.SK Chemicals Co. Ltd.
11 Apr 2025
Rhinitis, Allergic
South Korea
SK Chemicals Co. Ltd.SK Chemicals Co. Ltd.
11 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free